Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)

Kestra Medical Technologies (KMTS) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $280.5 million as the latest value for Q1 2025.

  • Quarterly Preferred Stock Liabilities changed N/A to $280.5 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $280.5 million through Jan 2025, changed N/A year-over-year, with the annual reading at $177.1 million for FY2024, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q1 2025 was $280.5 million at Kestra Medical Technologies, up from $177.1 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $280.5 million in Q1 2025, with the low at $177.1 million in Q2 2024.